Figure 3.
Variation in the percentages of ROS+ (a) and PS+ (b) RBCs in ESRD patients and healthy subjects (CTLs) measured by flow cytometry. PRE, POST: ESRD patients pre-HD and post-HD, respectively (**) p < 0.01 vs. controls.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.